A/P 12.5/15 (Alogliptin benzoate and pioglitazone hydrochloride 12.5 mg / 15 mg)

Pill imprint A/P 12.5/15 has been identified as Alogliptin benzoate and pioglitazone hydrochloride 12.5 mg / 15 mg.

Alogliptin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Alogliptin/pioglitazone 12.5 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alogliptin benzoate and pioglitazone hydrochloride

Imprint:

A/P 12.5/15

Strength:

12.5 mg / 15 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Perrigo New York Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.